Literature DB >> 8259052

Assessment of human colorectal biopsies by 1H MRS: correlation with histopathology.

C L Lean1, R C Newland, D A Ende, E L Bokey, I C Smith, C E Mountford.   

Abstract

Samples (3 mm3) of histopathologically normal (n = 15) and carcinomatous tissue (n = 15) were obtained from colectomy specimens and examined by 1H MRS. A combination of one- and two-dimensional spectra, obtained with appropriate acquisition and processing parameters, provide multiple diagnostic parameters allowing the distinction between normal and carcinomatous tissue. The diagnostic parameters include resonances from choline, choline-based, and other metabolites, cell surface fucosylation, and altered lipid profiles. Tissues histopathologically classified as normal, while remaining distinct from the malignant spectral profile, were found to fit into two categories, one of which had some of the spectral characteristics of malignancy. These results indicate that 1H MRS identifies abnormal colorectal mucosa, which is not morphologically manifest. Such abnormalities have been reported previously to exist in premalignant colorectal tissue by monoclonal antibody studies. Collectively, these results suggest that a clinical study of colorectal biopsies by 1H MRS could provide support for the use of MRS as an adjunct to current pathological procedures.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8259052     DOI: 10.1002/mrm.1910300502

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  16 in total

1.  Potential of magnetic resonance spectroscopy in assessing the effect of fatty acids on inflammatory bowel disease in an animal model.

Authors:  Sonal Varma; Michael N A Eskin; Ranjana Bird; Brion Dolenko; Jayadev Raju; Omkar B Ijare; Tedros Bezabeh
Journal:  Lipids       Date:  2010-08-19       Impact factor: 1.880

2.  Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.

Authors:  Lingli Deng; Haiwei Gu; Jiangjiang Zhu; G A Nagana Gowda; Danijel Djukovic; E Gabriela Chiorean; Daniel Raftery
Journal:  Anal Chem       Date:  2016-08-01       Impact factor: 6.986

Review 3.  Choline metabolism in malignant transformation.

Authors:  Kristine Glunde; Zaver M Bhujwalla; Sabrina M Ronen
Journal:  Nat Rev Cancer       Date:  2011-11-17       Impact factor: 60.716

Review 4.  MR-visible lipids and the tumor microenvironment.

Authors:  E James Delikatny; Sanjeev Chawla; Daniel-Joseph Leung; Harish Poptani
Journal:  NMR Biomed       Date:  2011-04-27       Impact factor: 4.044

5.  The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy.

Authors:  S R Maheshwari; S K Mukherji; B Neelon; S Schiro; G M Fatterpekar; J A Stone; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2000 Nov-Dec       Impact factor: 3.825

6.  Globally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad Coverage.

Authors:  Haiwei Gu; Ping Zhang; Jiangjiang Zhu; Daniel Raftery
Journal:  Anal Chem       Date:  2015-12-02       Impact factor: 6.986

7.  Characterization of synovial tissue from arthritis patients: a proton magnetic resonance spectroscopic investigation.

Authors:  Carol A Hitchon; Hani S El-Gabalawy; Tedros Bezabeh
Journal:  Rheumatol Int       Date:  2009-01-28       Impact factor: 2.631

8.  Non-invasive fecal metabonomic detection of colorectal cancer.

Authors:  Lee Cheng Phua; Xiu Ping Chue; Poh Koon Koh; Peh Yean Cheah; Han Kiat Ho; Eric Chun Yong Chan
Journal:  Cancer Biol Ther       Date:  2014-01-14       Impact factor: 4.742

9.  A prospective study of serum metabolites and colorectal cancer risk.

Authors:  Amanda J Cross; Steven C Moore; Simina Boca; Wen-Yi Huang; Xiaoqin Xiong; Rachael Stolzenberg-Solomon; Rashmi Sinha; Joshua N Sampson
Journal:  Cancer       Date:  2014-06-03       Impact factor: 6.860

10.  Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection.

Authors:  S Zoula; P F J W Rijken; J P W Peters; R Farion; B P J Van der Sanden; A J Van der Kogel; M Décorps; C Rémy
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.